EUVIMEDEUVIMED entdecken
Open Access

Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda

Melissa D Conrad iD, Victor Asua, Shreeya Garg, David Giesbrecht, Karamoko Niaré, Sawyer Smith, Jane F Namuganga, Thomas Katairo, Jennifer Legac, Rebecca M Crudale, Patrick K Tumwebaze, Samuel L Nsobya und 5 weitere

New England Journal of Medicine · 24.08.2023 · 389 (8) · 722-732

DOI: 10.1056/nejmoa2211803 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 24.08.2023. Verfasst von Melissa D Conrad und 16 weiteren Autor:innen. Beteiligte Einrichtung: From the University of California, San Francisco, San Francisco (M.D.C., S.G., J.L., G.D., P.J.R.); the Infectious Diseases Research Collaboration (V…. Hauptthemen laut MEDLINE: Artemisinins, Parasites, Drug Resistance, Malaria. Die Arbeit wurde bisher 220-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Partial resistance of Plasmodium falciparum to the artemisinin component of artemisinin-based combination therapies, the most important malaria drugs, emerged in Southeast Asia and now threatens East Africa. Partial resistance, which manifests as delayed clearance after therapy, is mediated principally by mutations in the kelch protein K13 (PfK13). Limited longitudinal data are available on the emergence and spread of artemisinin resistance in Africa. METHODS: We performed annual surveillance among patients who presented with uncomplicated malaria at 10 to 16 sites across Uganda from 2016 through 2022. We sequenced the gene encoding kelch 13 (pfk13) and analyzed relatedness using molecular methods. We assessed malaria metrics longitudinally in eight Ugandan districts from 2014 through 2021. RESULTS: By 2021-2022, the prevalence of parasites with validated or candidate resistance markers reached more than 20% in 11 of the 16 districts where surveillance was conducted. The PfK13 469Y and 675V mutations were seen in far northern Uganda in 2016-2017 and increased and spread thereafter, reaching a combined prevalence of 10 to 54% across much of northern Uganda, with spread to other regions. The 469F mutation reached a prevalence of 38 to 40% in one district in southwestern Uganda in 2021-2022. The 561H mutation, previously described in Rwanda, was first seen in southwestern Uganda in 2021, reaching a prevalence of 23% by 2022. The 441L mutation reached a prevalence of 12 to 23% in three districts in western Uganda in 2022. Genetic analysis indicated local emergence of mutant parasites independent of those in Southeast Asia. The emergence of resistance was observed predominantly in areas where effective malaria control had been discontinued or transmission was unstable. CONCLUSIONS: Data from Uganda showed the emergence of partial resistance to artemisinins in multiple geographic locations, with increasing prevalence and regional spread over time. (Funded by the National Institutes of Health.).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemisininsParasitesDrug ResistanceMalariaProtozoan ProteinsAnimalsHumansBenchmarkingUganda

Substanzen

artemisininArtemisininsProtozoan Proteins

Autor:innen und Institutionen

  • From the University of California, San Francisco, San Francisco (M.D.C., S.G., J.L., G.D., P.J.R.); the Infectious Diseases Research Collaboration (V.A., J.F.N., T.K., P.K.T., S.L.N., M.R.K.) and Makerere University (M.…

ORCID-Profile: Melissa D Conrad

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Conrad, M. D., Asua, V., Garg, S., Giesbrecht, D., Niaré, K., Smith, S., Namuganga, J. F., Katairo, T., Legac, J., Crudale, R. M., Tumwebaze, P. K., Nsobya, S. L., Cooper, R. A., Kamya, M. R., Dorsey, G., Bailey, J. A., & Rosenthal, P. J. (2023). Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda. New England Journal of Medicine, 389(8), 722-732. https://doi.org/10.1056/nejmoa2211803

Vancouver

Conrad MD, Asua V, Garg S, Giesbrecht D, Niaré K, Smith S, et al. Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda. New England Journal of Medicine. 2023;389(8):722-732. doi:10.1056/nejmoa2211803

BibTeX
@article{Conrad2023,
  author = {Conrad, Melissa D and Asua, Victor and Garg, Shreeya and Giesbrecht, David and Niaré, Karamoko and Smith, Sawyer and Namuganga, Jane F and Katairo, Thomas and Legac, Jennifer and Crudale, Rebecca M and Tumwebaze, Patrick K and Nsobya, Samuel L and Cooper, Roland A and Kamya, Moses R and Dorsey, Grant and Bailey, Jeffrey A and Rosenthal, Philip J},
  title = {Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {389},
  number = {8},
  pages = {722--732},
  doi = {10.1056/nejmoa2211803}
}
Kostenlos starten →